Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PSAP evaluated as a new urinary biomarker for monitoring Fabry's disease

Sep. 14, 2012

First-in-human results presented for a novel anti-HIV-1 vaccine

Sep. 14, 2012

SRI-011225 shows favorable toxicology and efficacy profile in vitro

Sep. 14, 2012

Astellas presents promising in vitro and in vivo results for a novel antifungal agent

Sep. 14, 2012

Galapagos presents promising in vivo results for GLPG-0492

Sep. 13, 2012

Results reported from phase II studies of BI-671800 in adult asthma

Sep. 13, 2012

Cubist Pharmaceuticals presents novel, broad-spectrum cephalosporin

Sep. 13, 2012

Frontier Biotechnologies presents early clinical data for albuvirtide

Sep. 13, 2012

Researchers from Peregrine present topline results from a phase II study in NSCLC

Sep. 12, 2012

Radiolabeled TSPO shows potential as a new imaging biomarker of NAFLD

Sep. 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...